ReviewTherapeutics and clinical risk management2021

Safety Profile of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease.

Ioannis BellosPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.